Tower Research Capital LLC (Trc) Immunocore Holdings PLC Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 686 shares of IMCR stock, worth $19,894. This represents 0.0% of its overall portfolio holdings.
Number of Shares
686
Previous 962
28.69%
Holding current value
$19,894
Previous $29,000
31.03%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding IMCR
# of Institutions
125Shares Held
42.5MCall Options Held
79.9KPut Options Held
46.2K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.7MShares$194 Million0.12% of portfolio
-
Wellington Management Group LLP Boston, MA6.62MShares$192 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$141 Million2.34% of portfolio
-
Primecap Management CO Pasadena, CA2.67MShares$77.4 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.19MShares$63.4 Million0.01% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.27B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...